Search results
You searched for:
Found 17 results
Date: 08/11/2023
In this on-demand webinar we explore the new era in opioid dependence treatment and unpack the implications of these transformative changes, highlighting how they democratise access to treatments, including Long-Acting Injectable Buprenorphine (LAIB). While
1 Educational activity hour
Date: 02/11/2023
The Australian National Men’s Health Strategy 2020-20301 identifies five priority health issues that are specific to males, or which disproportionately affect them. One of the five priority areas is sexual and reproductive healthThis webinar we provide up-to
1 Educational activity hour
Date: 01/01/2023
This two-part activity first introduces the various long-acting buprenorphine formulations available in Australia and their features, outlining steps in the assessment of patients with opioid dependence, and the determination of suitable treatment options in
1 Educational activity hour
1 Outcome measurement hour
Date: 27/02/2023
Quality care, particularly for chronic disease, requires a multidisciplinary approach to maximise patient outcomes.Completion of this module will enable practitioners to understand what multidisciplinary options might be available for their patients.This
0.5 Educational activity hour
0.5 Outcome measurement hour
Addressing health inequities
Professionalism
Ethical practice
Date: 06/03/2023
This module aims to increase the learner's knowledge and understanding of opioid dependence, assessment and treatment.NB: This is the first of two modules which require successful, sequential completion in order to apply for approval as a Level 2 QOTP
1 Educational activity hour
Ethical practice
Date: 01/01/2023
This module covers: What is opioid dependence?; Diagnostic criteria for opioid use disorder; Opioid pharmacotherapies in medication assisted treatment of opioid dependence (MATOD); Benefits of opioid agonist treatment; Long-acting injectable buprenorphine
Date: 27/02/2023
This module provides participants with the theoretical understanding and the evidence behind the benefits of opioid rotation. This module will provide an evidence-based approach to assist the practitioner in managing patients for whom an opioid rotation would
1 Educational activity hour
0.5 Outcome measurement hour
Date: 27/02/2023
This module provides participants with the theoretical understanding of the evidence behind off-label prescribing of quetiapine. It will assist the practitioner in managing patients who have been prescribed quetiapine for off-label use including identifying
0.5 Educational activity hour
0.5 Outcome measurement hour
Date: 18/01/2023
Food cravings are an intense desire to eat highly palatable and energy-dense foods and are among the main influencers of eating behaviour. In this module you will learn best practice steps to manage patients, then undertake a practical exercise to identify a
1 Educational activity hour
1 Outcome measurement hour
Date: 27/02/2023
This module will provide health practitioners with an in-depth understanding of the gabapentinoids (pregabalin and gabapentin), their evidence in practice, and some pragmatic approaches to improve the quality use of these agents.
0.5 Educational activity hour
0.5 Outcome measurement hour